Rosnew-ASP 20 Capsule IR
By Rosnew-ASP
Rx
10 Capsule IR in a Strip

Composition
Rosuvastatin(20mg) + Aspirin(75mg)

Manufacturer - Medocyte Pharmaceuticals
Plot no. 8, Udyog kunj, Jagdishpur road, Sonipat Sonipat, Haryana 131001

Expires on or after
November, 2027

liver
When using Rosnew-ASP 20 Capsule IR, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of Rosnew-ASP 20 Capsule IR in patients with liver issues, so consulting your doctor is advised. However, it is not recommended to use Rosnew-ASP 20 Capsule IR in patients with severe liver disease. Make sure to discuss your liver condition with your healthcare provider before starting this medication.

kidney
Rosnew-ASP 20 Capsule IR should be used carefully in patients with kidney disease. Adjusting the dosage may be necessary. Avoid using in severe kidney disease. Please consult your doctor for guidance.

alcohol
It is not safe to consume alcohol while taking Rosnew-ASP 20 Capsule IR.

driving
Rosnew-ASP 20 Capsule IR may cause reduced alertness, impact vision, and induce drowsiness and dizziness. It is advised not to drive if you experience these effects.

pregnancy
Rosnew-ASP 20 Capsule IR is considered highly unsafe for use during pregnancy. Studies on pregnant women and animals have indicated harmful effects on the developing baby. Seek your doctor's advice before using this medication in pregnancy.

breastfeeding
Rosnew-ASP 20 Capsule IR is considered unsafe during breastfeeding. Limited data indicates potential harm to the baby through passage into breastmilk.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | CARDIAC |
| Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
